Home Other Building Blocks 1,3,4,6-TETRACHLORO-3ALPHA,6ALPHA-DI-PHENYLGLYCOURIL

1,3,4,6-TETRACHLORO-3ALPHA,6ALPHA-DI-PHENYLGLYCOURIL

CAS No.:
51592-06-4
Catalog Number:
AG00D9PK
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00D9PK
Chemical Name:
1,3,4,6-TETRACHLORO-3ALPHA,6ALPHA-DI-PHENYLGLYCOURIL
CAS Number:
51592-06-4
MDL Number:
MFCD00027367
IUPAC Name:
1,3,4,6-tetrachloro-3a,6a-diphenylimidazo[4,5-d]imidazole-2,5-dione
InChI:
InChI=1S/C16H10Cl4N4O2/c17-21-13(25)23(19)16(12-9-5-2-6-10-12)15(21,11-7-3-1-4-8-11)22(18)14(26)24(16)20/h1-10H
InChI Key:
FJQZXCPWAGYPSD-UHFFFAOYSA-N
NSC Number:
4462
Properties
Complexity:
533  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
431.953g/mol
Formal Charge:
0
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
432.082g/mol
Monoisotopic Mass:
429.956g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
47.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.2  
Literature
Title Journal
A robust approach to enhance tumor-selective accumulation of nanoparticles. Oncotarget 20110201
Pharmacokinetics, tissue distribution and excretion of porcine fibrinogen after intraperitoneal injection of a porcine-derived fibrin glue to rats. Journal of pharmaceutical and biomedical analysis 20110105
Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors. PloS one 20110101
CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer. International journal of molecular imaging 20110101
Erythrocyte and porcine intestinal glycosphingolipids recognized by F4 fimbriae of enterotoxigenic Escherichia coli. PloS one 20110101
Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer. European journal of medicinal chemistry 20100901
Deficiency of activating Fcγ-receptors reduces hepatic clearance and deposition of IC and increases CIC levels in mercury-induced autoimmunity. PloS one 20100101
(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy. European journal of nuclear medicine and molecular imaging 20090801
Glycosylation directs targeting and activation of cystatin f from intracellular and extracellular sources. Traffic (Copenhagen, Denmark) 20090401
Generation and characterization of monoclonal antibodies against prostate-specific antigen. Hybridoma (2005) 20090401
A simple and safe method for 131I radiolabeling of rituximab for myeloablative high-dose radioimmunotherapy. Cancer biotherapy & radiopharmaceuticals 20090201
[In vitro cytotoxicity of 131I-Rituximab against B-cell lymphoma cells]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20090101
Sulfatide recognition by colonization factor antigen CS6 from enterotoxigenic Escherichia coli. PloS one 20090101
OXavidin for tissue targeting biotinylated therapeutics. Journal of biomedicine & biotechnology 20090101
Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS pathogens 20080801
Strategies to maximize the encapsulation efficiency of phenylalanine ammonia lyase in microcapsules. International journal of pharmaceutics 20080522
Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays. Critical care (London, England) 20080101
Pharmacokinetics of GST-TatdMt, a recombinant fusion protein possessing potent anti-obesity activity, in mice. Archives of pharmacal research 20070901
Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models. British journal of cancer 20070618
Analysis of iodinated peptides by LC-DAD/ESI ion trap mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
Pharmacokinetics of 125I-GST-TatdMt, a recombinant fusion protein possessing potent anti-obesity activity, after intravenous, nasal, oral, and subcutaneous administration. Regulatory peptides 20070405
Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor. Nuclear medicine and biology 20070401
Protein aggregation and degradation during iodine labeling and its consequences for protein adsorption to biomaterials. Analytical biochemistry 20070201
Validation of 8-[123I]iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid as an imaging agent for prostate cancer in experimental models of human prostate cancer. Nuclear medicine and biology 20070101
Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic (Copenhagen, Denmark) 20060901
Preparation and tumor affinity testing of the radioiodinated tetrahydroisoquinoline derivative [123I]TIC(OH) for targeting prostate cancer. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20060501
[Biological response of B-cell lymphoma cells in vitro to 131I-rituximab]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20060201
Dose-linear pharmacokinetics, tissue distribution, and excretion of a recombinant fusion protein 125I-GST-TatdMt possessing potent anti-obesity activity. Regulatory peptides 20050715
[Killing effect of 131I-Herceptin on breast cancer cell lines in vitro]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20050601
Radiolabeling of amyloid-beta peptides. Methods in molecular biology (Clifton, N.J.) 20050101
Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy. A review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Göttingen/Marburg experience. Nuklearmedizin. Nuclear medicine 20020401
Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate. Nuclear medicine and biology 20020101
Comparison of two methods for radioiodination on the oxidizability properties of low density lipoprotein. Journal of physiology and biochemistry 20011201
Self-radioiodination of iodogen. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20010501
Determination of the specific antibody titer. Current protocols in molecular biology 20010501
Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010301
Surface component characterization as taxonomic tools for Phytomonas spp identification. Parasitology research 20010201
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20010201
The IODO-GEN method for labeling and the use of retrograde axonal transport to assay neurotrophins. Methods in molecular biology (Clifton, N.J.) 20010101
Properties